Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pabst

Showing results (201-210 of 332) with videos related to

Pageof 34
Sort By:
Bone Marrow Transplantation|March 28, 2020
A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patientsBarbara Jeker, Sarah Farag, Behrouz Mansouri Taleghani, et al.
Haematologica|July 11, 2015
Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOGRoland B Walter, Megan Othus, Bob Löwenberg, et al.
Bone Marrow Transplantation|August 28, 2023
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMTJia Chen, Myriam Labopin, Thomas Pabst, et al.
Annals of Hematology|June 28, 2018
Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literatureAlexander Simonis, Michaela Fux, Gayathri Nair, et al.
Academic Radiology|February 10, 2023
Diffusion-weighted Breast MRI at 3 Tesla: Improved Lesion Visibility and Image Quality with a Combination of Water-excitation and Spectral Fat SaturationStephanie Tina Sauer, Sara Aniki Christner, Tanja Schlaiß, et al.
Annals of Hematology|July 17, 2024
Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expressionMax J Rieger, Thomas Pabst, Barbara Jeker, et al.
Cell Reports. Medicine|September 8, 2023
PARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapyBruktawit Maru, Alessandra Messikommer, Linhui Huang, et al.
British Journal of Haematology|December 20, 2021
Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphomaStefanie Kreissl, Conrad-Amadeus Voltin, Helen Kaul, et al.
Plos One|September 23, 2014
Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemiaMonique Terwijn, Wendelien Zeijlemaker, Angèle Kelder, et al.
Leukemia|January 12, 2023
Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trialThilo Zander, Thomas Pabst, Sämi Schär, et al.
Pageof 34

Showing results (201-210 of 332) with videos related to

Sort By:
Pageof 34
Bone Marrow Transplantation|March 28, 2020
A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patientsBarbara Jeker, Sarah Farag, Behrouz Mansouri Taleghani, et al.
Haematologica|July 11, 2015
Empiric definition of eligibility criteria for clinical trials in relapsed/refractory acute myeloid leukemia: analysis of 1,892 patients from HOVON/SAKK and SWOGRoland B Walter, Megan Othus, Bob Löwenberg, et al.
Bone Marrow Transplantation|August 28, 2023
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMTJia Chen, Myriam Labopin, Thomas Pabst, et al.
Annals of Hematology|June 28, 2018
Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literatureAlexander Simonis, Michaela Fux, Gayathri Nair, et al.
Academic Radiology|February 10, 2023
Diffusion-weighted Breast MRI at 3 Tesla: Improved Lesion Visibility and Image Quality with a Combination of Water-excitation and Spectral Fat SaturationStephanie Tina Sauer, Sara Aniki Christner, Tanja Schlaiß, et al.
Annals of Hematology|July 17, 2024
Three years follow-up of Venetoclax in advanced-stage, relapsed or refractory AL amyloidosis with cardiac involvement and t(11;14) with BCL2 expressionMax J Rieger, Thomas Pabst, Barbara Jeker, et al.
Cell Reports. Medicine|September 8, 2023
PARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapyBruktawit Maru, Alessandra Messikommer, Linhui Huang, et al.
British Journal of Haematology|December 20, 2021
Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphomaStefanie Kreissl, Conrad-Amadeus Voltin, Helen Kaul, et al.
Plos One|September 23, 2014
Leukemic stem cell frequency: a strong biomarker for clinical outcome in acute myeloid leukemiaMonique Terwijn, Wendelien Zeijlemaker, Angèle Kelder, et al.
Leukemia|January 12, 2023
Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trialThilo Zander, Thomas Pabst, Sämi Schär, et al.
Pageof 34